220 related articles for article (PubMed ID: 36375645)
1. Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36/TRPC6/NFAT2 signaling in type 2 diabetes mellitus mice.
Han Y; Su Y; Han M; Liu Y; Shi Q; Li X; Wang P; Li W; Li W
J Ethnopharmacol; 2023 Feb; 302(Pt A):115923. PubMed ID: 36375645
[TBL] [Abstract][Full Text] [Related]
2. Palmitate induces human glomerular mesangial cells fibrosis through CD36-mediated transient receptor potential canonical channel 6/nuclear factor of activated T cell 2 activation.
Su Y; Chen Q; Ju Y; Li W; Li W
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158793. PubMed ID: 32800850
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg1 attenuates lipopolysaccharide-induced chronic liver damage by activating Nrf2 signaling and inhibiting inflammasomes in hepatic cells.
Zhou H; Liu Y; Su Y; Ji P; Kong L; Sun R; Zhang D; Xu H; Li W; Li W
J Ethnopharmacol; 2024 Apr; 324():117794. PubMed ID: 38244950
[TBL] [Abstract][Full Text] [Related]
4. Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36/fibrosis pathway.
Zou TF; Liu ZG; Cao PC; Zheng SH; Guo WT; Wang TX; Chen YL; Duan YJ; Li QS; Liao CZ; Xie ZL; Han JH; Yang XX
Acta Pharmacol Sin; 2023 Oct; 44(10):2065-2074. PubMed ID: 37225845
[TBL] [Abstract][Full Text] [Related]
5.
Sun R; Han M; Liu Y; Su Y; Shi Q; Huang L; Kong L; Li W; Li W
Mol Med Rep; 2024 Jan; 29(1):. PubMed ID: 38038121
[TBL] [Abstract][Full Text] [Related]
6. Cortex Mori Radicis Attenuates Streptozotocin-induced Diabetic Renal Injury in Mice
Zhai Y; Li D; Wang Z; Shao L; Yin N; Li W
Endocr Metab Immune Disord Drug Targets; 2022; 22(8):862-873. PubMed ID: 35016601
[TBL] [Abstract][Full Text] [Related]
7. Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-β1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy.
Du N; Xu Z; Gao M; Liu P; Sun B; Cao X
Drug Des Devel Ther; 2018; 12():3517-3524. PubMed ID: 30425453
[TBL] [Abstract][Full Text] [Related]
8. Transient receptor potential canonical 6 knockdown ameliorated diabetic kidney disease by inhibiting nuclear factor of activated T cells 2 expression in glomerular mesangial cells.
Yu J; Li C; Ma L; Zhai B; Xu A; Shao D
Ren Fail; 2022 Dec; 44(1):1780-1790. PubMed ID: 36285371
[TBL] [Abstract][Full Text] [Related]
9. Trpc6 knockout improves behavioral dysfunction and reduces Aβ production by inhibiting CN-NFAT1 signaling in T2DM mice.
Kong L; Sun R; Zhou H; Shi Q; Liu Y; Han M; Li W; Qun S; Li W
Exp Neurol; 2023 May; 363():114350. PubMed ID: 36791875
[TBL] [Abstract][Full Text] [Related]
10. Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho/TGF-β1/p38MAPK signaling pathway.
Gu LY; Yun-Sun ; Tang HT; Xu ZX
J Ethnopharmacol; 2021 Dec; 281():113548. PubMed ID: 33152427
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg1 treatment protects against cognitive dysfunction via inhibiting PLC-CN-NFAT1 signaling in T2DM mice.
Dong X; Kong L; Huang L; Su Y; Li X; Yang L; Ji P; Li W; Li W
J Ginseng Res; 2023 May; 47(3):458-468. PubMed ID: 37252275
[TBL] [Abstract][Full Text] [Related]
12. Piperlonguminine attenuates renal fibrosis by inhibiting TRPC6.
Zhou L; Wu K; Gao Y; Qiao R; Tang N; Dong D; Li XQ; Nong Q; Luo DQ; Xiao Q; Fan X; Duan Q; Cao W
J Ethnopharmacol; 2023 Sep; 313():116561. PubMed ID: 37121453
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV inhibits palmitate-mediated oxidative stress and fibrosis in human glomerular mesangial cells via downregulation of CD36 expression.
Su Y; Chen Q; Ma K; Ju Y; Ji T; Wang Z; Li W; Li W
Pharmacol Rep; 2019 Apr; 71(2):319-329. PubMed ID: 30826573
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4-MAPK pathway in T2DM mice.
Ji P; Shi Q; Liu Y; Han M; Su Y; Sun R; Zhou H; Li W; Li W
Ren Fail; 2023 Dec; 45(1):2197075. PubMed ID: 37017270
[TBL] [Abstract][Full Text] [Related]
15. Betanin, isolated from fruits of Opuntia elatior Mill attenuates renal fibrosis in diabetic rats through regulating oxidative stress and TGF-β pathway.
Sutariya B; Saraf M
J Ethnopharmacol; 2017 Feb; 198():432-443. PubMed ID: 28111218
[TBL] [Abstract][Full Text] [Related]
16. C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway.
Li L; Yin Q; Tang X; Bai L; Zhang J; Gou S; Zhu H; Cheng J; Fu P; Liu F
PLoS One; 2014; 9(11):e113639. PubMed ID: 25422985
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg1 attenuates the inflammation and oxidative stress induced by diabetic nephropathy through regulating the PI3K/AKT/FOXO3 pathway.
Liu H; Chen W; Lu P; Ma Y; Liang X; Liu Y
Ann Transl Med; 2021 Dec; 9(24):1789. PubMed ID: 35071483
[TBL] [Abstract][Full Text] [Related]
18. Nepeta angustifolia C. Y. Wu improves renal injury in HFD/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells.
Huang S; Tan M; Guo F; Dong L; Liu Z; Yuan R; Dongzhi Z; Lee DS; Wang Y; Li B
J Ethnopharmacol; 2020 Jun; 255():112771. PubMed ID: 32201300
[TBL] [Abstract][Full Text] [Related]
19. Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis
Li X; Zhang T; Geng J; Wu Z; Xu L; Liu J; Tian J; Zhou Z; Nie J; Bai X
Antioxid Redox Signal; 2019 Sep; 31(7):521-538. PubMed ID: 31084358
[No Abstract] [Full Text] [Related]
20. Integrating metabolomics and network pharmacology to investigate Panax japonicus prevents kidney injury in HFD/STZ-induced diabetic mice.
Wang T; Huang X; Zhai K; Yu J; Li J; Duan H; Liu J; Lu Z; Guo J; Li F
J Ethnopharmacol; 2023 Mar; 303():115893. PubMed ID: 36368565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
